Pentraxin‐3 and the Right Ventricle: The Multi‐Ethnic Study of Atherosclerosis–Right Ventricle Study
Open Access
- 1 June 2014
- journal article
- research article
- Published by Wiley in Pulmonary Circulation
- Vol. 4 (2) , 250-259
Abstract
Pentraxin-3 (PTX3) is a protein mediator of innate immunity that is elevated in the setting of left heart disease and pulmonary arterial hypertension. The relationship between PTX3 and right ventricular (RV) structure and function is not known. We included men and women with magnetic resonance imaging assessment of RV structure and function and measurement of PTX3 from the Multi-Ethnic Study of Atherosclerosis, a study of individuals free of clinical cardiovascular disease. Multivariable linear regression estimated associations between PTX3 protein levels and RV measures after adjusting for demographic characteristics, anthropometrics, smoking status, diabetes mellitus, hypertension, and corresponding left ventricular (LV) parameters. Instrumental variable analysis exploiting Mendelian randomization was attempted using two-stage least squares regression. The study sample included 1,779 participants with available PTX3 levels, RV measures, and all covariables. Mean PTX3 level was 2.1 ng/mL. Higher PTX3 was independently associated with greater RV mass and larger RV end-diastolic volume with and without adjustment for the corresponding LV parameters or C-reactive protein (all P < .05). There was no association between PTX3 and RV ejection fraction or stroke volume. Single-nucleotide polymorphisms were not associated with PTX3 protein levels or RV measures after accounting for race. Instrumental variable analysis could not be reliably performed. Higher PTX3 protein levels were associated with greater RV mass and larger RV end-diastolic volume. These associations were independent of common cardiovascular risk factors and LV morphologic changes. Inflammation is associated with differences in the pulmonary circulation-RV axis in adults without clinical cardiovascular disease.Keywords
Funding Information
- National Center for Advancing Translational Sciences
- National Institutes of Health (KL2TR000421)
This publication has 44 references indexed in Scilit:
- Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF TrialsEuropean Journal of Heart Failure, 2012
- Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of AtherosclerosisNephrology Dialysis Transplantation, 2010
- PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patientsGenes & Immunity, 2010
- Relation of Cardiovascular Risk Factors to Right Ventricular Structure and Function as Determined by Magnetic Resonance Imaging (Results from the Multi-Ethnic Study of Atherosclerosis)The American Journal of Cardiology, 2010
- Reproducibility and Validity of Lung Density Measures from Cardiac CT Scans—The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study1Academic Radiology, 2009
- Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The Relationship of Left Ventricular Mass and Geometry to Incident Cardiovascular EventsJACC, 2008
- ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: The multi-ethnic study of atherosclerosis (MESA)Atherosclerosis, 2008
- Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial InfarctionCirculation, 2008
- Traditional Cardiovascular Risk Factors in Relation to Left Ventricular Mass, Volume, and Systolic Function by Cardiac Magnetic Resonance ImagingJACC, 2006